We therefore treated the APL cell line NB4 and the two non-APL cell lines; HL60 and MOLM-13, with TNFα (10 nM) or ATRA (10 μM) for 24 h separately or in combination. The gene discussed is TNF; the disease is acute promyelocytic leukemia.